drugset / Trial / NCT00570128
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether donepezil HCl is effective and safe in improving cognitive dysfunction exhibited by children and adolescents with Down syndrome (DS). Effectiveness will be measured by rating communication, daily living skills, and social skills and relationships in subjects aged 10 to 17.
Timeline
- Start
- 2007-11-16
- Primary completion
- 2008-09-05
- Completion
- 2008-09-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Donepezil | Small molecule | 2.5 mg | Oral |
| Comparator | Donepezil | Small molecule | 5 mg | Oral |
| Comparator | Donepezil | Small molecule | 10 mg | Oral |